Lincomycin
Lincomycin Injection, USP
Approved
Approval ID
61f4851d-d919-400d-912a-05eb9dca11d4
Product Type
HUMAN PRESCRIPTION DRUG LABEL
Effective Date
Oct 14, 2022
Manufacturers
FDA
XGen Pharmaceuticals DJB, Inc.
DUNS: 117380305
Products 2
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
lincomycin hydrochloride
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
NDC Product Code39822-0350
Application NumberANDA201746
Product Classification
M
Marketing Category
C73584
G
Generic Name
lincomycin hydrochloride
Product Specifications
Route of AdministrationINTRAMUSCULAR, INTRAVENOUS, SUBCONJUNCTIVAL
Effective DateOctober 14, 2022
FDA Product Classification
INGREDIENTS (2)
BENZYL ALCOHOLInactive
Quantity: 9.45 mg in 1 mL
Code: LKG8494WBH
Classification: IACT
LINCOMYCIN HYDROCHLORIDEActive
Quantity: 300 mg in 1 mL
Code: M6T05Z2B68
Classification: ACTIM
lincomycin hydrochloride
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
NDC Product Code39822-0353
Application NumberANDA201746
Product Classification
M
Marketing Category
C73584
G
Generic Name
lincomycin hydrochloride
Product Specifications
Route of AdministrationINTRAMUSCULAR, INTRAVENOUS, SUBCONJUNCTIVAL
Effective DateOctober 14, 2022
FDA Product Classification
INGREDIENTS (2)
BENZYL ALCOHOLInactive
Quantity: 9.45 mg in 1 mL
Code: LKG8494WBH
Classification: IACT
LINCOMYCIN HYDROCHLORIDEActive
Quantity: 300 mg in 1 mL
Code: M6T05Z2B68
Classification: ACTIM